---
schema_version: "secwatch.filing_event.v1"
accession: "0001438133-23-000005"
form_type: "8-K"
ticker: "TNDM"
cik: "0001438133"
company_name: "TANDEM DIABETES CARE INC"
filed_at: "2023-01-10T23:59:59+00:00"
generated_at: "2026-06-20T17:02:31.271067+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Tandem Diabetes announces preliminary FY2022 results and FY2023 guidance; no specific figures disclosed in filing text

## Summary
- Press release contains unaudited preliminary Q4 and full-year 2022 results.
- Results are preliminary and subject to adjustment; final audited results will be in the 10-K.
- Company also provided preliminary financial guidance for the full year ending December 31, 2023.
- Exhibit 99.1 text was not included in the provided filing, so specific numbers are unavailable.

## SEC filing metadata
- accession: 0001438133-23-000005
- form_type: 8-K
- ticker: TNDM
- cik: 0001438133
- company_name: TANDEM DIABETES CARE INC
- filed_at: 2023-01-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1438133/000143813323000005/0001438133-23-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1438133/000143813323000005/tndm-20230110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001438133-23-000005
- JSON: https://secwatch.observer/filing/0001438133-23-000005.json
- Plain text: https://secwatch.observer/filing/0001438133-23-000005.txt

## Key facts
- Earnings Releases
  TANDEM DIABETES CARE INC updated its the quarter and full year ended December 31, 2022 guidance (initiated).
  - Period: the quarter and full year ended December 31, 2022
  - Guidance: initiated
  - Result: preliminary results
  source text: On January 10, 2023 , the Company issued a press release announcing its unaudited, preliminary financial results for the quarter and full year ended December 31, 2022, as well as its preliminary financial guidance for the full year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1438133/000143813323000005/0001438133-23-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.